This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Bayer Healthcare LLC, Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 790 
2 out of 721 
1 out of 387 
Years Active: 2014-2020
Title: Juergen Stiehl: Innovator in Pharmaceutical Chemistry
Introduction
Juergen Stiehl is a notable inventor based in Sprockhövel, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of five patents. His work primarily focuses on innovative processes for drug preparation, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Among his latest patents is a process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide. This invention relates to a method for synthesizing a complex compound that has potential applications in pharmaceuticals. Another significant patent involves the synthesis of copanlisib and its dihydrochloride salt. This invention presents a novel method for preparing copanlisib, along with its hydrates, and introduces new intermediate compounds that facilitate this process.
Career Highlights
Juergen Stiehl has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Healthcare LLC. His experience in these organizations has allowed him to collaborate on various innovative projects, contributing to the development of new therapeutic solutions.
Collaborations
Throughout his career, Stiehl has collaborated with esteemed colleagues such as Werner Heilmann and Michael Lögers. These partnerships have further enriched his work and expanded the impact of his inventions in the pharmaceutical sector.
Conclusion
Juergen Stiehl's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative processes continue to pave the way for advancements in drug development and medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile